These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24728124)

  • 1. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2014 Jun; 44(6):1895-903. PubMed ID: 24728124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen).
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Ibuki N; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2013 Oct; 43(4):1087-94. PubMed ID: 23934264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer.
    Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Komura K; Uehara H; Minami K; Yamamoto K; Narumi Y
    Int J Oncol; 2019 Jan; 54(1):167-176. PubMed ID: 30387836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen).
    Azuma H; Inamoto T; Takahara K; Nomi H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Yamamoto K; Narumi Y; Kiyama S
    Int J Oncol; 2013 Jul; 43(1):79-87. PubMed ID: 23624911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.
    Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
    Int J Oncol; 2011 Jan; 38(1):13-24. PubMed ID: 21109921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
    Int J Oncol; 2010 Oct; 37(4):773-85. PubMed ID: 20811698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bladder preservation therapy with Osaka Medical College regimen.
    Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
    J Urol; 2015 Feb; 193(2):443-50. PubMed ID: 25167990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
    Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
    Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of Radiation Therapy in Bladder Preservation Therapy for Patients With Clinical Stage T2N0M0 Bladder Cancer.
    Nakata M; Shimbo T; Kihara A; Sato C; Hori A; Yoshioka H; Yoshida K; Nihei K
    Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):e430-e436. PubMed ID: 35715341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Results of Radiotherapy Combined with Balloon-occluded Arterial Infusion Chemotherapy for Invasive Bladder Cancer.
    Yoshioka H; Shimbo T; Yoshida K; Yoshikawa N; Uesugi Y; Yamamoto K; Azuma H; Narumi Y
    Anticancer Res; 2016 Feb; 36(2):731-6. PubMed ID: 26851031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
    Gamal El-Deen HS
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):133-46. PubMed ID: 19034344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    Coen JJ; Zhang P; Saylor PJ; Lee CT; Wu CL; Parker W; Lautenschlaeger T; Zietman AL; Efstathiou JA; Jani AB; Kucuk O; Souhami L; Rodgers JP; Sandler HM; Shipley WU
    J Clin Oncol; 2019 Jan; 37(1):44-51. PubMed ID: 30433852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
    Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
    J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer.
    Cobo M; Delgado R; Gil S; Herruzo I; Baena V; Carabante F; Moreno P; Ruiz JL; Bretón JJ; Del Rosal JM; Fuentes C; Moreno P; García E; Villar E; Contreras J; Alés I; Benavides M
    Clin Transl Oncol; 2006 Dec; 8(12):903-11. PubMed ID: 17169764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial.
    Azria D; Riou O; Rebillard X; Thezenas S; Thuret R; Fenoglietto P; Pouessel D; Culine S
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):853-9. PubMed ID: 24368064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study.
    Shi H; Zhang W; Bi X; Wang D; Xiao Z; Guan Y; Guan K; Tian J; Bai H; Hu L; Cao C; Jiang W; Hu Z; Zhang J; Chen Y; Zheng S; Feng X; Li C; Li Y; Ma J; Liu Y; Zhou A; Shou J
    Cancer Res Treat; 2021 Oct; 53(4):1156-1165. PubMed ID: 33592141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen.
    Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Yamamoto K; Narumi Y; Ubai T
    Int J Urol; 2012 Jan; 19(1):26-38. PubMed ID: 22077821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT).
    Tunio MA; Hashmi A; Rafi M; Qayyum A; Masood R
    J Pak Med Assoc; 2011 Jan; 61(1):6-10. PubMed ID: 22368893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
    Mitin T; George A; Zietman AL; Heney NM; Kaufman DS; Uzzo RG; Dreicer R; Wallace HJ; Souhami L; Dobelbower MC; Sandler HM; Shipley WU
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):67-74. PubMed ID: 26700703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.